This provides evidence for the novel regulatory role of tumor-derived exosomal lncRNA HEIH targeting the miR-98-5p/STAT3 axis in macrophages, aiding the understanding of the complex interactions between the TME and immune cells in HCC treatment (73). The gene discussed is HEIH; the disease is neoplasm.